Not your institution?

Works matching AU Sansa-Girona, Júlia

Results: 3
    1

    TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.

    Published in:
    Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00503-9
    By:
    • Gallo-Oller, Gabriel;
    • Pons, Guillem;
    • Sansa-Girona, Júlia;
    • Navarro, Natalia;
    • Zarzosa, Patricia;
    • García-Gilabert, Lia;
    • Cabré-Fernandez, Paula;
    • Guillén Burrieza, Gabriela;
    • Valero-Arrese, Lorena;
    • Segura, Miguel F.;
    • Lizcano, José M.;
    • Sánchez de Toledo, José;
    • Moreno, Lucas;
    • Gallego, Soledad;
    • Roma, Josep
    Publication type:
    Article
    2
    3

    Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.

    Published in:
    Cellular & Molecular Life Sciences, 2022, v. 79, n. 11, p. 1, doi. 10.1007/s00018-022-04557-y
    By:
    • Navarro, Natalia;
    • Molist, Carla;
    • Sansa-Girona, Júlia;
    • Zarzosa, Patricia;
    • Gallo-Oller, Gabriel;
    • Pons, Guillem;
    • Magdaleno, Ainara;
    • Guillén, Gabriela;
    • Hladun, Raquel;
    • Garrido, Marta;
    • Segura, Miguel F.;
    • Hontecillas-Prieto, Lourdes;
    • de Álava, Enrique;
    • Ponsati, Berta;
    • Fernández-Carneado, Jimena;
    • Almazán-Moga, Ana;
    • Vallès-Miret, Mariona;
    • Farrera-Sinfreu, Josep;
    • de Toledo, Josep Sánchez;
    • Moreno, Lucas
    Publication type:
    Article